These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7563656)

  • 21. [A case of interstitial pneumonia with chronic hepatitis C following interferon-alfa and sho-saiko-to therapy].
    Sugiyama H; Nagai M; Kotajima F; Yoshizawa A; Kamimura M; Horiuchi T; Kudo K; Kabe J; Hayashi S; Umeda N
    Arerugi; 1995 Jul; 44(7):711-4. PubMed ID: 7575138
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial comparing three different regimens of interferon alfa 2a in chronic hepatitis C.
    Angelico M
    Hepatology; 1996 Jun; 23(6):1709-10. PubMed ID: 8675201
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
    Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
    Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alfa-2b induced long-term relief of pain in two patients with adiposis dolorosa and chronic hepatitis C.
    Gonciarz Z; Mazur W; Hartleb J; Machniak M; Bednarek I; Mazurek U; Wilczok T
    J Hepatol; 1997 Dec; 27(6):1141. PubMed ID: 9453446
    [No Abstract]   [Full Text] [Related]  

  • 28. Containing hepatitis C.
    Maddrey WC
    Hosp Pract (1995); 1997 Mar; 32(3):107-9, 113-4 passim; discussion 128. PubMed ID: 9078976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term therapy with recombinant interferon alpha 2 b in patients with chronic hepatitis C: effects on thyroid function and autoantibodies.
    Barreca T; Picciotto A; Franceschini R; Varagona G; Corsini G; Valle F; Cataldi A; Molinari E; Garibaldi A; Rolandi E
    J Biol Regul Homeost Agents; 1993; 7(2):58-62. PubMed ID: 8266816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term response to interferon-alfa 2b re-treatment in chronic hepatitis C.
    Saracco G; Rosina F; Abate ML; Carucci P; Solinas A; Chiandussi L; Bonino F; Verme G; Rizzetto M
    J Hepatol; 1994 Aug; 21(2):278-9. PubMed ID: 7989724
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment algorithms for hepatitis B and C.
    Schiff ER
    Gut; 1993; 34(2 Suppl):S148-9. PubMed ID: 8314487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C.
    Arai H; Tanaka M; Ohta K; Kojo T; Niijima K; Imawari M
    Lancet; 1995 Mar; 345(8949):582. PubMed ID: 7677847
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of chorea-like movement induced during interferon treatment of chronic hepatitis C].
    Yoshikubo S; Kimura K; Mizuashi K; Kamo S; Maeda K; Kobatake S
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):1036-8. PubMed ID: 9340345
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of ischemic colitis associated with interferon treatment].
    Horigome H; Takezono Y; Fujino N; Uchida A; Murasaki G
    Nihon Shokakibyo Gakkai Zasshi; 1996 Mar; 93(3):181-4. PubMed ID: 8721113
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of chronic hepatitis C developing drug induced intrahepatic cholestasis due to anti-inflammatory drug during interferon therapy].
    Niiya M; Suzuki K; Naito Y; Konuma Y; Fujise K; Watanabe R
    Nihon Shokakibyo Gakkai Zasshi; 1996 Apr; 93(4):272-5. PubMed ID: 8656571
    [No Abstract]   [Full Text] [Related]  

  • 36. Could chelation therapy with deferoxamine enhance the percentage of responders to interferon therapy in chronic hepatitis C?
    Leonardi S; Musumeci S
    Acta Haematol; 1993; 90(4):211-2. PubMed ID: 8140864
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-induced psoriasis in a patient with chronic hepatitis C.
    Garcia-Lora E; Tercedor J; Massare E; López-Nevot MA; Skiljo M; Garcia-Mellado V
    Dermatology; 1993; 187(4):280. PubMed ID: 8274788
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon-alpha 2b interaction with acenocoumarol.
    Serratrice J; Durand JM; Morange S
    Am J Hematol; 1998 Jan; 57(1):89. PubMed ID: 9423826
    [No Abstract]   [Full Text] [Related]  

  • 39. Consensus panel advocates prolonged interferon treatment for chronic hepatitis C.
    Am J Health Syst Pharm; 1997 May; 54(10):1140, 1145. PubMed ID: 9161619
    [No Abstract]   [Full Text] [Related]  

  • 40. [Late fever under recombinant alfa interferon].
    Gaudin JL; Dumortier J; Souquet JC; Bel A
    Presse Med; 1994 Jun; 23(22):1041. PubMed ID: 7971811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.